Your browser doesn't support javascript.
loading
In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
Ni, Wentao; Wang, Yifan; Ma, Xinqian; He, Yukun; Zhao, Jin; Guan, Jie; Li, Yanjun; Gao, Zhancheng.
Afiliação
  • Ni W; Department of Pulmonary and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China. wentao.qingdao@163.com.
  • Wang Y; Department of Pulmonary and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China.
  • Ma X; Department of Pulmonary and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China.
  • He Y; Department of Pulmonary and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China.
  • Zhao J; Department of Respiratory Diseases, Air Force Medical Center, Chinese People's Liberation Army, Beijing, China.
  • Guan J; Clinical Laboratory, Peking University First Hospital, Beijing, China.
  • Li Y; Clinical Laboratory, The Sixth Medical Center of PLA General Hospital, Beijing, China. liyanjun1230@163.com.
  • Gao Z; Department of Pulmonary and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China. zcgao@bjmu.edu.cn.
Eur J Clin Microbiol Infect Dis ; 41(12): 1451-1457, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36201141

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Acinetobacter baumannii Limite: Humans Idioma: En Revista: Eur J Clin Microbiol Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Acinetobacter baumannii Limite: Humans Idioma: En Revista: Eur J Clin Microbiol Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China